mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.003 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.003 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |